Antibiotic Use and Antimicrobial Treatment of Sepsis, ICU Infections and Other Critical Infections
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 307
Special Issue Editor
Interests: emergency medicine; sepsis; intensive care medicine; trauma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Critical infections can lead to a high mortality. Critical infections are currently the most serious type of disease threatening the life of patients in ICUs. Infections in ICUs are the most common cause of preventable death, causing annual health care costs to increase by billions of dollars. Some of the most-common serious infections in hospitals are pneumonia and sepsis. After critical infections, early antibiotic treatment is required. The use of ineffective antibiotics and low-dose antibiotics has led to the emergence of more and more resistant strains, and thus the use of antibiotics in critical infections needs to be optimized. The ability of early empirical antibiotic therapy to effectively fight the pathogens of severe infections has a great impact on prognosis. This Special Issue focuses on manuscripts related to the antibiotic use and antimicrobial treatment of sepsis and critical infections. This Special Issue welcomes contributions that explore antibiotics and antibacterial therapy in sepsis, ICU infections and other critical infections, from basic science to clinical medicine, including the optimization of antibiotic use, pharmacokinetics, and research into related drug-resistant pathogens.
Dr. Yutaka Kondo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
